Biomarkers for antitumor activity of bevacizumab in gastric cancer models

BACKGROUND: Bevacizumab is a humanized monoclonal antibody to human vascular endothelial cell growth factor (VEGF) and has been used for many types of cancers such as colorectal cancer, non-small cell lung cancer, breast cancer, and glioblastoma. Bevacizumab might be effective against gastric cancer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yamashita-Kashima, Yoriko, Fujimoto-Ouchi, Kaori, Yorozu, Keigo, Kurasawa, Mitsue, Yanagisawa, Mieko, Yasuno, Hideyuki, Mori, Kazushige
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3292441/
https://ncbi.nlm.nih.gov/pubmed/22273502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-37
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars